Results 151 to 160 of about 1,835 (171)

THSD7A-Associated Membranous Nephropathy in a Patient With Neurofibromatosis Type 1

European Journal of Medical Genetics, 2018
Target antigens in idiopathic membranous nephropathy (MN) include the phospholipase A2 receptor (PLA2R), and in some cases, the thrombospondin type 1 domain-containing 7A (THSD7A). A notable phenomenon is the high rate of cancer (reported to be as high as 20%) in patients with THSD7A-associated MN.
Wenbin Guan, Xuanli Tang, Fujun Lin
exaly   +3 more sources

THSD7A Staining of Membranous Glomerulopathy in Clinical Practice Reveals Cases With Dual Autoantibody Positivity [PDF]

Modern Pathology, 2016
Thrombospondin type I domain-containing 7A (THSD7A) is a known antigenic target of autoantibodies leading to primary membranous glomerulopathy and was reported to account for ~10% of phospholipase A2 receptor (PLA2R)-negative membranous glomerulopathy.
Christopher P Larsen, Laurence H Beck
exaly   +3 more sources

Down-Regulation of miRNA-1303 Promotes the Angiogenesis of HUVECs via Targeting THSD7A

Molecular Biotechnology, 2023
Angiogenesis promotes neurological recovery after acute ischemic stroke (AIS), and microRNAs play crucial roles in cerebral angiogenesis. This study found that Homo sapiens-microRNA-1303(miR-1303) was reduced in blood specimens of AIS patients and human umbilical vein endothelial cells after suffering from oxygen-glucose deprivation/reperfusion.
Guoliang Xiang, Yanan Zhao, Di Jin, Yanbo Fang, Zhiyi Li, Xiaofeng He, Yifei Zhai, Junfang Teng, Wenjing Deng   +8 more
openaire   +2 more sources

Non-Pathogenetic THSD7A Antibodies in a Patient with No Membranous Nephropathy

Journal of the American Society of Nephrology, 2021
Linda Reinhard, Cindy Thomas, Maya Machalitza, Erik Lattwein, Lothar S. Weiß, Jan Vitu, Thorsten Wiech, Rolf A. Stahl, Elion Hoxha   +8 more
openaire   +1 more source

Lack of replication of association of THSD7A with obesity

International Journal of Obesity, 2016
M, Ahmad, S S, Nongmaithem, G V, Krishnaveni, C H D, Fall, C S, Yajnik, G R, Chandak   +5 more
openaire   +2 more sources

Reply to ‘Lack of replication of association of THSD7A with obesity’

International Journal of Obesity, 2016
Nizamuddin, S, Govindaraj, P, Saxena, S, Kashyap, M, Mishra, A, Singh, S, Rotti, H, Raval, R, Nayak, J, Bhat, BK, Prasanna, BV, Dhumal, VR, Bhale, S, Joshi, KS, Dedge, AP, Bharadwaj, R, Gangadharan, GG, Nair, S, Gopinath, PM, Patwardhan, B, Kondaiah, P, Satyamoorthy, K, Valiathan, MS, Thangaraj, K   +23 more
openaire   +3 more sources

Ethnic difference frequencies of THSD7A variant, but no association with obesity

Anthropologie, 2021
Soňa Mačeková, Matúš Mathia, Zuzana Varaliová, Jarmila Bernasovská, Iveta Boroňová, Dana Dojčaková, Eva Petrejčíková, Jana Galová, Hedvika Vašková   +8 more
openaire   +1 more source

THSD7A as a marker for paraneoplastic membranous nephropathy

International Urology and Nephrology, 2019
Tao Wang, Yan Zhang, MaoDong Liu, Xi Kang, Lin Kang, Hui Zhang   +5 more
openaire   +1 more source

THSD7A Cleavage Is Mediated by the Proprotein Convertase Furin In Vitro

Journal of the American Society of Nephrology, 2022
Larissa Seifert, Silke Dehde, Renke Lucas, Gunther Zahner, Nicola M. Tomas   +4 more
openaire   +1 more source

THSD7A Expression: A Novel Immunohistochemical Determinant in Predicting Overall Survival of Metastatic Renal Cell Carcinoma Treated With Targeted Therapy

Irish Journal of Medical Science, 2022
Mustafa Erman, Suayib Yalcin, Taha Koray Şahin   +2 more
exaly